GSK plc (GSK)
Develops vaccines and medicines to prevent and treat diseases like cancer, respiratory conditions, and infections
$53.90+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+43.7%
The outlook
GSK is trading at $53.90, positioned well above its 50- and 200-day moving averages and about 69% up from its 52-week low. Analyst consensus leans toward Hold, with an average price target sitting roughly 8% above the current price. The stock scores a leaning-bullish outlook on StockGlow, though coverage sentiment remains cautious overall.
What’s behind the score
Analyst consensusHold — 2.9 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range69% of the way from its 52-week low to high
Price targetAvg target +8% vs current price
Analyst price target
~12-month · 8 analysts$58.08average target+7.8% vs now
Now $53.90
Low $47.00High $70.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$61.70
52-wk low
$36.75
50-day avg
$51.51
200-day avg
$51.42
Trailing P/E
14.3